Synergistic Effect of Network-Based Multicomponent Drugs: An Investigation on the Treatment of Non-Small-Cell Lung Cancer With Compound Liuju Formula

Evidence-based Complementary and Alternative Medicine - Egypt
doi 10.1155/2019/9854047
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Using a Network-Based Approach

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Individualized Treatment of Advanced Non-Small Cell Lung Cancer Based on Analytic Hierarchy Process

World Journal of Cancer Research
2017English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

PLoS ONE
Multidisciplinary
2013English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

P2.01-017 Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy